Acquirer(s)

  • Cell Care Australia Pty Ltd

Target(s)

  • Cryosite Limited

Summary

The ACCC has decided that it will not make a decision on whether to grant clearance for the proposed acquisition under section 50 of the Competition and Consumer Act (CCA), and will discontinue its public review of the proposed acquisition. The ACCC is continuing to investigate the circumstances surrounding entry into the agreement and the closing of Cryosite?s cord blood and tissue collection operations

Timeline

Date Event

ACCC commenced review under the Merger Process Guidelines.

Closing date for submissions from interested parties.

ACCC requested further information from Cryosite Limited.

ACCC received further information from Cell Care Australia Pty Ltd.

ACCC is awaiting information from Cryosite Limited and Cell Care Australia Pty Ltd. Former provisional date for announcement of ACCC's findings (16 November) is delayed. ACCC will announce a proposed decision date in due course.

After considering the information available to it, the ACCC has decided that it will not make a decision on whether to grant clearance for the proposed acquisition under section 50 of the Competition and Consumer Act (CCA), and will discontinue its public review of the proposed acquisition.